STVN:NYE-Stevanato Group SpA (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 19.27

Change

-0.03 (-0.16)%

Market Cap

USD 5.62B

Volume

0.39M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-2.77 (-1.18%)

USD 67.65B
ALC Alcon AG

-1.46 (-1.48%)

USD 48.64B
RMD ResMed Inc

-0.89 (-0.35%)

USD 35.98B
BAX Baxter International Inc

-0.45 (-1.12%)

USD 20.54B
AVTR Avantor Inc

-0.33 (-1.21%)

USD 18.49B
TFX Teleflex Incorporated

-4.61 (-1.87%)

USD 11.63B
ATR AptarGroup Inc

+0.04 (+0.03%)

USD 10.16B
BLCO Bausch + Lomb Corp

+0.76 (+4.27%)

USD 6.26B
WRBY Warby Parker Inc

-0.12 (-0.80%)

USD 1.57B
INFU InfuSystems Holdings Inc

-0.09 (-1.38%)

USD 0.14B

ETFs Containing STVN

ZEB:CA BMO S&P/TSX Equal Weight .. 17.16 % 0.60 %

+0.08 (+-0.13%)

CAD 2.68B
CIC:CA CI Canadian Banks Covered.. 16.75 % 0.84 %

+0.04 (+-0.13%)

N/A
BNC:CA 13.14 % 0.68 %

N/A

N/A
ZWB:CA BMO Covered Call Canadian.. 11.72 % 0.71 %

+0.03 (+-0.13%)

CAD 3.03B
HCB:CA 6.95 % 0.65 %

N/A

N/A
BFIN-U:CA 5.72 % 0.00 %

N/A

N/A
XDV:CA iShares Canadian Select D.. 5.67 % 0.55 %

+0.04 (+-0.13%)

CAD 1.66B
QXM:CA First Asset Morningstar N.. 5.11 % 0.58 %

N/A

CAD 0.07B
INOC:CA Global X Inovestor Canadi.. 4.05 % 0.66 %

-0.04 (-0.13%)

CAD 0.04B
PDC:CA Invesco Canadian Dividend.. 3.90 % 0.55 %

+0.04 (+-0.13%)

CAD 0.79B
XFN:CA iShares S&P/TSX Capped Fi.. 3.81 % 0.61 %

+0.04 (+-0.13%)

CAD 1.49B
XCG:CA iShares Canadian Growth 3.13 % 0.55 %

-0.26 (-0.13%)

CAD 0.09B
FBE:CA 2.65 % 0.83 %

N/A

N/A
DXIF:CA Dynamic Active Internatio.. 0.00 % 0.00 %

-0.03 (-0.13%)

CAD 4.17M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.39% 11% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.39% 11% F 6% D-
Trailing 12 Months  
Capital Gain -34.39% 11% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.39% 11% F 6% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 15.98% 79% B- 79% B-
Dividend Return 15.98% 79% B- 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 42.31% 47% F 22% F
Risk Adjusted Return 37.77% 84% B 56% F
Market Capitalization 5.62B 50% F 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.